Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular components are targeted and damaged through the combined effects of a photosensitizer, light of a specific wavelength, and molecular oxygen, leading to the generation of reactive oxygen species (ROS). This process is central to photodynamic therapy (PDT), a treatment modality used in cancer and other diseases. Major targets include plasma membrane lipids/proteins, cytoskeletal elements (tubulin), ion channels (TRPA1/TRPV1), and signal transduction proteins/pathways (ERK/Akt/EGFR). This results in membrane disruption/inactivation, mitotic arrest/cell cycle disruption, altered ion fluxes/calcium signaling, and modulated growth/survival signaling.
Light-excited photosensitizers generate ROS that oxidatively modify/damage essential biomolecules within illuminated cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular components via photodynamic action (N/A).